Literature DB >> 3623011

A diagnostic marker of autoimmune chronic active hepatitis: liver plasma membrane antibody in the serum absorbed with particulate fraction of kidney homogenate.

G Toda, Y Ikeda, N Hashimoto, T Maruyama, H Oka.   

Abstract

The sera absorbed with the particulate fraction of rabbit kidney homogenate (RK) were tested for the antibody against liver plasma membrane (LPM-Ab) by the radiometric assay method. After incubation of the isolated rabbit liver plasma membrane (RLPM) with appropriately diluted serum, IgG bound to RLPM (IgG-RLPM) was determined using 125I-labelled Staphylococcal protein A. IgG-RLPM in each subject tested was expressed in arbitrary units, that is, the multiple of the mean radioactivity associated with RLPM in 35 control subjects. Thus IgG-RLPM was 1.00 (mean) +/- 0.23 (SD) in the control subjects, 1.13 +/- 0.30 in 9 patients with chronic persistent hepatitis (CPH), 1.13 +/- 0.52 in 15 with chronic active hepatitis (CAH), 1.34 +/- 0.38 in 23 with liver cirrhosis (LC) and 3.45 +/- 0.73 in 5 with autoimmune CAH. F(ab')2 fragments from a patient with autoimmune CAH and a control subject decreased IgG-RLPM by 86.4 +/- 6.35 and -5.2 +/- 14.9%, respectively, in four patients with autoimmune CAH. LPM-Ab was detected in 0, 20.0 and 17.4% in the patients with CPH, CAH and LC, respectively. All of the patients with autoimmune CAH were positive for LPM-Ab. The absorption of the sera positive for LPM-Ab with RK decreased IgG-RLPM in various extents. In two of five patients with autoimmune CAH and two of seven patients with CAH or LC, the majority of LPM-Ab was cross-reactive with RK.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3623011     DOI: 10.1007/bf02774256

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  22 in total

1.  Association of autoimmune active chronic hepatitis with HL-A1,8.

Authors:  I R Mackay; P J Morris
Journal:  Lancet       Date:  1972-10-14       Impact factor: 79.321

2.  Studies on plasma membranes. XVI. Tissue specific antigens in the liver cell surface.

Authors:  J B Sheffield; P Emmelot
Journal:  Exp Cell Res       Date:  1972-03       Impact factor: 3.905

3.  Antibodies to liver membrane antigens in chronic active hepatitis (CAH). II. Specificity for autoimmune CAH.

Authors:  I H Frazer; I J Kronborg; I R Mackay
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

4.  Liver-specific and shared cell membrane antigens. Studies by light- and electron microscopy.

Authors:  U J Behrens; F Paronetto
Journal:  Immunology       Date:  1978-08       Impact factor: 7.397

5.  Effect of corticosteroids on suppressor-cell activity in "autoimmune" and viral chronic active hepatitis.

Authors:  K T Nouri-Aria; J E Hegarty; G J Alexander; A L Eddleston; R Williams
Journal:  N Engl J Med       Date:  1982-11-18       Impact factor: 91.245

6.  Liver cell membrane antibody detected by protein A and isolated rabbit liver plasma membrane in sera of patients with chronic liver diseases.

Authors:  G Toda; Y Ikeda; N Hashimoto; M Yamazaki; M Torii; H Oka
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

7.  Liver cell surface expression of the antigen reacting with liver-kidney microsomal antibody (LKM).

Authors:  M Lenzi; F B Bianchi; F Cassani; E Pisi
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

8.  Clinical evaluation of the liver cell membrane autoantibody assay.

Authors:  H J Schuurman; A J Vogten; S W Schalm; J Fevery
Journal:  Digestion       Date:  1982       Impact factor: 3.216

9.  Antibodies to liver cell membrane antigens in chronic active hepatitis (CAH). III. Partial characterization of the liver cell membrane antigens and comparison of reactivities in sera from patients with various liver diseases.

Authors:  I H Frazer; I R Mackay
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

10.  Detection and characterization of liver membrane autoantibodies in chronic active hepatitis by a solid-phase radioimmunoassay.

Authors:  M Manns; K H Meyer zum Büschenfelde; T H Hütteroth; G Hess
Journal:  Clin Exp Immunol       Date:  1980-11       Impact factor: 4.330

View more
  1 in total

1.  Non-enzymatic decomposition of collagen fibers by a biglycan antibody and a plausible mechanism for rheumatoid arthritis.

Authors:  Olga Antipova; Joseph P R O Orgel
Journal:  PLoS One       Date:  2012-03-13       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.